TenGen Biomedical Overview
- Year Founded
-
2000
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$597K
- Investors
-
2
TenGen Biomedical General Information
Description
Developer of vaccine candidates designed to prevent viral infectious diseases and cancer. The company's products include vertebrate-specific replication-defective viruses and virus-like particle (VLP)-based technologies for the development of vaccines against the Zika virus, dengue virus, and other viral diseases, enabling researchers and healthcare providers to advance vaccine development and disease prevention.
Contact Information
Website
www.tengen-biomed.comCorporate Office
- 7220 Grubby Thicket Way
- Bethesda, MD 20817-1510
- United States
Corporate Office
- 7220 Grubby Thicket Way
- Bethesda, MD 20817-1510
- United States
TenGen Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Grant | 01-Jan-2022 | $597K | Completed | Startup | ||
| 4. Accelerator/Incubator | 01-Feb-2021 | Completed | Startup | |||
| 3. Grant | 01-Aug-2017 | Completed | Startup | |||
| 2. Grant | 01-Aug-2017 | $652K | Completed | Startup | ||
| 1. Grant | 01-Jan-2006 | $499K | Completed | Startup |
TenGen Biomedical Comparisons
Industry
Financing
Details
TenGen Biomedical Competitors (12)
One of TenGen Biomedical’s 12 competitors is Genentech, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genentech | Formerly VC-backed | South San Francisco, CA | ||||
| Merck & Co. | Corporation | Rahway, NJ | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Ona Therapeutics | Venture Capital-Backed | Barcelona, Spain |
TenGen Biomedical Patents
TenGen Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2023145738-A | Mammal-specific growth defective arbovirus | Pending | 11-Sep-2017 | ||
| EP-3681522-A1 | Mammal-specific growth-defective arbovirus | Pending | 11-Sep-2017 | ||
| EP-3681522-A4 | Mammal-specific growth-defective arbovirus | Pending | 11-Sep-2017 | ||
| US-12098393-B2 | Mammal-specific growth-defective arbovirus | Active | 11-Sep-2017 | ||
| WO-2019051445-A1 | Mammal-specific growth-defective arbovirus | Inactive | 11-Sep-2017 | C12N7/00 |
TenGen Biomedical Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| U.S. Department of Health and Human Services | Government |
TenGen Biomedical FAQs
-
When was TenGen Biomedical founded?
TenGen Biomedical was founded in 2000.
-
Where is TenGen Biomedical headquartered?
TenGen Biomedical is headquartered in Bethesda, MD.
-
What industry is TenGen Biomedical in?
TenGen Biomedical’s primary industry is Drug Discovery.
-
Is TenGen Biomedical a private or public company?
TenGen Biomedical is a Private company.
-
What is TenGen Biomedical’s current revenue?
The current revenue for TenGen Biomedical is .
-
How much funding has TenGen Biomedical raised over time?
TenGen Biomedical has raised $3M.
-
Who are TenGen Biomedical’s investors?
National Institutes of Health and U.S. Department of Health and Human Services have invested in TenGen Biomedical.
-
Who are TenGen Biomedical’s competitors?
Genentech, Merck & Co., Ability Pharma, Gilead, and Ona Therapeutics are some of the 12 competitors of TenGen Biomedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process